Home > Insider Trading > Filing (0001209191-19-062322)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1755237	Cyclerion Therapeutics Inc.	CYCN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1478244	G Mark Currie	C/O Cyclerion Therapeutics, Inc. 301 Binney Street Cambridge MA 02142	President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-12-27	25,000	$2.55	296,755	No	4	S	Direct
Common Stock	Disposition	2019-12-30	25,000	$2.48	271,755	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The proceeds from the sale are intended to cover income taxes arising out of prior stock option exercises, including those in which the reporting person held the underlying shares.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.